Moriah J Brier1, Dianne L Chambless1, Robert Gross2,3, Jinbo Chen4, Jun J Mao5. 1. Department of Psychology, University of Pennsylvania, Philadelphia, Pennsylvania. 2. Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. 3. Philadelphia Veterans Administration Medical Center, Philadelphia, Pennsylvania. 4. Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. 5. Integrative Medicine Service, The Bendheim Integrative Medicine Center, Memorial Sloan Kettering Cancer Center, New York, New York.
Abstract
BACKGROUND: Although poor adherence to hormonal therapies such as aromatase inhibitors (AIs) is widely documented, to the authors' knowledge less is known regarding whether health beliefs predict treatment nonadherence. The objective of the current study was to evaluate the relationship between health beliefs (perceived susceptibility to breast cancer, perceived benefits of AI treatment, and perceived barriers to AI treatment) and adherence to AIs. METHODS: Postmenopausal women with early-stage, estrogen receptor-positive breast cancer who were currently receiving treatment with an AI completed the 3-factor Health Beliefs and Medication Adherence in Breast Cancer scale and questionnaires concerning their demographics and symptoms. Adherence data (treatment gaps and premature discontinuation) were abstracted from participants' medical charts. Logistic regression analyses were conducted to evaluate the relationship between health beliefs and adherence. RESULTS: Among 437 participants, 93 (21.3%) were nonadherent. Those who perceived greater barriers to their AI treatment were more likely to demonstrate AI nonadherence behaviors by the end of their treatment period compared with those who reported fewer barriers to AI therapy (adjusted odds ratio, 1.71; 95% confidence interval, 1.03-2.86 [P = .04]). In contrast, perceived susceptibility to cancer recurrence and perceived benefits of AIs did not appear to predict AI adherence. Minority individuals were found to have lower perceived susceptibility to breast cancer recurrence and higher perceived barriers to AI treatment (P<.05 for both). CONCLUSIONS: Greater perceived barriers appeared to predict nonadherence to AIs. Interventions addressing women's negative beliefs regarding the challenges of AI treatment are needed to help optimize adherence in survivors of breast cancer. Cancer 2017;169-176.
BACKGROUND: Although poor adherence to hormonal therapies such as aromatase inhibitors (AIs) is widely documented, to the authors' knowledge less is known regarding whether health beliefs predict treatment nonadherence. The objective of the current study was to evaluate the relationship between health beliefs (perceived susceptibility to breast cancer, perceived benefits of AI treatment, and perceived barriers to AI treatment) and adherence to AIs. METHODS: Postmenopausal women with early-stage, estrogen receptor-positive breast cancer who were currently receiving treatment with an AI completed the 3-factor Health Beliefs and Medication Adherence in Breast Cancer scale and questionnaires concerning their demographics and symptoms. Adherence data (treatment gaps and premature discontinuation) were abstracted from participants' medical charts. Logistic regression analyses were conducted to evaluate the relationship between health beliefs and adherence. RESULTS: Among 437 participants, 93 (21.3%) were nonadherent. Those who perceived greater barriers to their AI treatment were more likely to demonstrate AI nonadherence behaviors by the end of their treatment period compared with those who reported fewer barriers to AI therapy (adjusted odds ratio, 1.71; 95% confidence interval, 1.03-2.86 [P = .04]). In contrast, perceived susceptibility to cancer recurrence and perceived benefits of AIs did not appear to predict AI adherence. Minority individuals were found to have lower perceived susceptibility to breast cancer recurrence and higher perceived barriers to AI treatment (P<.05 for both). CONCLUSIONS: Greater perceived barriers appeared to predict nonadherence to AIs. Interventions addressing women's negative beliefs regarding the challenges of AI treatment are needed to help optimize adherence in survivors of breast cancer. Cancer 2017;169-176.
Authors: Christos Markopoulos; Patrick Neven; Minna Tanner; Michael Marty; Rolf Kreienberg; Louise Atkins; Ann Franquet; Michael Gnant; Silvia Neciosup; Petra Tesarova; Sandro Barni; Veronique Deschamp Journal: Future Oncol Date: 2015 Impact factor: 3.404
Authors: Jun J Mao; Sharon X Xie; John T Farrar; Carrie T Stricker; Marjorie A Bowman; Deborah Bruner; Angela DeMichele Journal: Eur J Cancer Date: 2013-10-24 Impact factor: 9.162
Authors: Vanessa B Sheppard; Leigh Anne Faul; George Luta; Jonathan D Clapp; Rachel L Yung; Judy Huei-Yu Wang; Gretchen Kimmick; Claudine Isaacs; Michelle Tallarico; William T Barry; Brandelyn N Pitcher; Clifford Hudis; Eric P Winer; Harvey J Cohen; Hyman B Muss; Arti Hurria; Jeanne S Mandelblatt Journal: J Clin Oncol Date: 2014-06-16 Impact factor: 44.544
Authors: Aliza K Fink; Jerry Gurwitz; William Rakowski; Edward Guadagnoli; Rebecca A Silliman Journal: J Clin Oncol Date: 2004-08-15 Impact factor: 44.544
Authors: Kannie Chim; Sharon X Xie; Carrie T Stricker; Qing S Li; Robert Gross; John T Farrar; Angela DeMichele; Jun J Mao Journal: BMC Cancer Date: 2013-09-03 Impact factor: 4.430
Authors: Ilana Graetz; Caitlin N McKillop; Edward Stepanski; Gregory A Vidal; Janeane N Anderson; Lee S Schwartzberg Journal: J Cancer Surviv Date: 2018-02-28 Impact factor: 4.442
Authors: Ting Bao; Susan Q Li; Josh L Dearing; Lauren A Piulson; Christina M Seluzicki; Robert Sidlow; Jun J Mao Journal: Acupunct Med Date: 2018-02-10 Impact factor: 2.267
Authors: Kate E Roberts; India T Adsett; Kirsty Rickett; Sophie M Conroy; Mark D Chatfield; Natasha E Woodward Journal: Cochrane Database Syst Rev Date: 2022-01-10
Authors: Kelsey E Larson; Stephanie A Valente; Chirag Shah; Rahul D Tendulkar; Sheen Cherian; Jame Abraham; Courtney Yanda; Chao Tu; Jessica Echle; Stephen R Grobmyer Journal: Mol Clin Oncol Date: 2018-08-23
Authors: Andrew J Paladino; Janeane N Anderson; Rebecca A Krukowski; Teresa Waters; Mehmet Kocak; Carolyn Graff; Ryan Blue; Tameka N Jones; Joanne Buzaglo; Gregory Vidal; Lee Schwartzberg; Ilana Graetz Journal: BMC Health Serv Res Date: 2019-12-19 Impact factor: 2.655